Abstract: Podoplanin, a transmembrane sialomucin-like glycoprotein, is a specific marker of lymphatic vessels, and its expression is also considered to be associated with tumor invasion and tooth development. In this study, we examined the expression of podoplanin in calcifying cystic odontogenic tumor (CCOT) in comparison with that in other so-called hard α-keratin-expressing tumors such as craniopharyngioma (CP) and pilomatrixoma (PM). Immunohistochemical staining for podoplanin was carried out using surgical specimens of 15 CCOTs of the jaw, 19 CPs of the pituitary gland, and 15 PMs of the skin. Positivity for hard α-keratin was evident in ghost, shadow and transitional cells in all of these tumors (100%). The podoplanin expression in CCOTs was evident in the periphery of ameloblastoma-like epithelium (86.6%) and the epithelial cells adjacent to ghost cells (60%). On the other hand, in adamantinomatous-type CPs, podoplanin expression was observed in epithelial components corresponding to the stratum intermedium (100%), but not in the periphery of ameloblastoma-like epithelium (0%). In squamoustype CPs podoplanin was expressed in basal cells (100%), but all of the PMs were podoplanin-negative (0%). In the periphery of the ameloblastoma-like epithelium or basophilic cell layer, podoplanin was expressed more strongly in CCOTs than in CPs or PMs. These findings suggest that the expression of podoplanin in CCOTs may reflect rapid turnover of cytoskeletal filaments and local invasiveness. (J Oral Sci 54, [165][166][167][168][169][170][171][172][173][174][175] 2012) 
Introduction
Calcifying odontogenic cyst (COC) was first described by Gorlin et al. (1) in 1962 as a specific histological entity. In 1971, the World Health Organization (WHO) described COC as a "non-neoplastic" cystic lesion (2) . Thereafter, in 1992, COC was classified as an odontogenic tumor (3) . In the latest WHO classification, published in 2005, the term COC was changed to calcifying cystic odontogenic tumor (CCOT) to reflect its neoplastic nature (4) . CCOT is a benign cystic odontogenic neoplasm characterized by proliferation of ameloblastoma-like epithelium with ghost cells, local invasiveness and a rare tendency for recurrence (5) . Although some studies have described the clinical and histopathological features of COC, those studies focused on its immunohistochemical profile, and few investigations have addressed its proliferative activity (6) (7) (8) . The mechanisms involved in the progression and invasiveness of CCOT are still unknown.
Expression of podoplanin has been found in various neoplasms, and its association with invasiveness has been suggested, in view of the ability of the protein to induce actin remodeling in tumor cells (9) (10) (11) (12) (13) (14) . The purpose of the present study was to examine the localization of podoplanin in CCOT and to clarify the role of the protein.
Human podoplanin (T1α-2, aggrus or gp36) is a 38-kDa type-1 transmembrane sialomucin-like glycoprotein consisting of 162 amino acids, nine of which form its intracellular domain. Although the protein has been considered a specific marker of lymphatic endothelial cells (15) (16) (17) (18) (19) , its expression has also been demonstrated in various normal as well as neoplastic tissues (9) (10) (11) (12) (13) (14) . In addition, it has been reported that podoplanin expression is biologically related to cell migration and invasion (20) (21) (22) . In odontogenic lesions, we have previously shown that podoplanin is expressed in ameloblastoma, Fig. 1 Scalp skin hair follicles and oral leukoplakias were used as positive and negative controls for hard α-keratin, respectively (×200 magnification). (A) H&E staining of scalp skin hair follicles; (B) strong immunoreactivity for hard α-keratin was detected in the cortex of the hair shafts (red arrowheads); (C) H&E staining of oral leukoplakia; (D) immunoreactivity for hard α-keratin was not detected in the hyperkeratotic layer (black arrowheads).
keratocystic odontogenic tumor, and odontoma (23) (24) (25) . In the present study using immunohistochemical methods, we analyzed the expression of podoplanin in CCOT to evaluate the correlation between podoplanin and the neoplastic character of the tumor. In addition to CCOT, two other tumor types are known to display ghost cells or their homologue, shadow cells: adamantinomatous craniopharyngioma (CP) of the pituitary gland (26) and pilomatrixoma (PM) of the skin (27) , which are tumors expressing hard α-keratin (28) . The expression pattern of podoplanin in CCOT was compared with that in CP and PM, and the significance of the protein in these three tumor types was considered.
Materials and Methods

Tissue samples
Formalin-fixed, paraffin-embedded tissue samples from 15 cases of CCOT, 19 cases of CP, and 15 cases of PM were used. Sections of normal head skin, oral mucosa, oral leukoplakia and hemangioma were used as control samples. Each section was prepared for immunohistochemical analysis.
Immunohistochemical analysis
Deparaffinized sections were immersed in absolute methanol containing 0.3% H 2 O 2 for 20 min at room temperature to block endogenous peroxidase activity. After washing with phosphate-buffered saline (PBS, 0.01 M phosphate buffer, 0.15 M NaCl, pH 7.4), the sections were incubated in 2% bovine serum albumin in PBS for 15 min at room temperature to block nonspecific reactions. Appropriately diluted rabbit polyclonal antibody against hard α-keratin (10 μg/mL, 1:400) (28) was applied to each section for 60 min at room temperature. After washing with PBS the slides were incubated with a prediluted anti-rabbit IgG antibody conjugated with peroxidase (Nichirei, Tokyo, Japan) for 30 min at room temperature. After washing with PBS, the sections were immersed for 10 min in 0.05% 3,3'-diaminobenzidine tetrahydrochloride (DAB, Sigma Chemical Industries, St. Louis, MO, USA) in 0.05 M Tris-HCl buffer (pH 7.6) containing 0.01% H 2 O 2 . After washing with PBS, an appropriately diluted mouse monoclonal anti-human D2-40 (anti-podoplanin antibody; Dako North America, Inc., Carpinteria, CA, USA) was applied to each section for 60 min at room temperature, followed by a prediluted anti-mouse IgG antibody conjugated with peroxidase (Nichirei) for 30 min at room temperature. After washing with PBS, the sections were incubated with HistoGreen substrate (AbCys s.a., Paris, France) solution at room temperature until a sufficient color intensity had been attained within 1-5 min. After another wash with PBS, the sections were counterstained with Mayer's hematoxylin.
The present study was performed with approval from the Research Ethics Committee of Meikai University School of Dentistry (A0832).
Results
Expression of hard α-keratin in CCOT, CP, and PM Immunoreactivity for hard α-keratin was found in hair shafts of normal head skin (Fig. 1A, B) but not in the hyperkeratotic layer of oral leukoplakia (Fig. 1C, D) . In all 15 CCOTs, hard α-keratin was detected only in ghost cells ( Fig. 2A-D) , and not in any other epithelial components (Table 1) (Fig. 2E-I ). Among the 19 cases of CP, 9 were the adamantinomatous type with shadow cells, and 10 were the squamous type without shadow cells ( (Fig. 4A, B ). In the 3 PMs at the late regressive stage, bone metaplasia was evident, and immunoreactivity for hard α-keratin was observed only in shadow cells (Table  1) (Fig. 4C, D) . The immunostaining patterns for hard α-keratin in CCOT, CP and PM are detailed in Table 2 .
Podoplanin expression in CCOT, CP, and PM Podoplanin was expressed only in lymphatic vessels of the normal oral mucosa (data not shown). In all 15 CCOTs, positivity for podoplanin was found mainly in marginal epithelial cells of tumor nests (Table 1) , ameloblastoma-like epithelium ( Fig. 2A, B) , and proliferative areas of cord-like odontogenic epithelium (Fig. 2C, D) . Sometimes, epithelial components adjacent to ghost cells were also positive for podoplanin (Table 1) (Fig. 2E,  F) . In one case of CCOT with odontoma, positivity for podoplanin was observed in pulp cells, odontoblasts and dentinal tubules of tooth-like structures ( Fig. 2G-I ).
Among the 19 cases of CP, a positive reaction was found mainly in epithelial cells corresponding to the stratum intermedium in 9 of the adamantinomatous-type CPs (Fig. 3A-D) , and expression of the protein was detected mainly in marginal basaloid cells of the 10 squamous-type CPs (Fig. 3E, F) .
No podoplanin positivity was evident in any of the PMs (Table 1) (Fig. 4A, B) . Immunoreactivity for podoplanin was found in osteoblast-like or osteocyte-like and hard α-keratin (red arrowheads); (I) high-power magnification shows podoplanin in the dental pulp, odontoblasts and intra-dentinal tubules of the tooth (green arrowheads) (×400 magnification).
cells at the late regressive stage (Fig. 4C, D) . The pattern of immunostaining for podoplanin varied in CCOT, CP and PM (Table 3) .
Discussion
CCOT is characterized by an ameloblastomatous epithelium with ghost cells that may calcify, local invasiveness and rare recurrence (4, 5) . Other odontogenic tumors in which ghost cells appear as a secondary phenomenon include odontoma (29) (30) (31) (32) (33) (34) (35) . With regard to the origin of ghost cells, it is thought that odontogenic epithelium undergoes metaplastic transformation with keratinization (32, 33, 35) . Levy (29) has suggested that, in the course of metaplasia, squamous metaplasia likely occurs due to a reduction in the supply of oxygen, resulting in ischemic change, cell death and keratinization, thus leading to formation of ghost cells. One ultrastructural study has shown that although ghost cells lack keratohyaline granules, they do contain abundant tonofilaments and probably represent an altered form of keratin (33) . In an immunohistochemical analysis, Piattelli and Trisi (35) demonstrated that ghost cells were negative for normal keratin. Furthermore, scanning electron microscopy studies have shown that the pattern formed by large tonofilament bundles in ghost cells is unlike that normally found in orthokeratinized or parakeratinized epithelium, and since the production of keratin is not a natural function of odontogenic epithelium, the ultrastructural features of ghost cell keratinization should be interpreted as indicating the production of an aberrant or unusual form of keratin, and not true keratin (29) (30) (31) . However, CCOTs, including adamantinomatous-type CP and PM, express hard α-keratin in ghost cells and shadow cells (28) . Ghost cells in CCOT and shadow cells in adamantinomatous-type CP appear randomly, but shadow cells in PM appear through a shift of tran- regulated by the action of caspase-14. Further studies of keratinocyte denucleation in normal and tumor epithelium are needed to shed further light on this issue. In CCOT, expression of podoplanin was observed mainly in the basal layer of the tumor epithelium and cord-like proliferative odontogenic epithelium. Similar patterns of immunoreactivity for podoplanin have been described in ameloblastoma or keratocystic odontogenic tumor (23, 24) . Its expression might be related to cell migration and local invasion of odontogenic tumors. The expression of podoplanin is upregulated in a number of different human cancers, including those of the oral cavity, larynx, lung, uterine cervix, esophagus, skin, ovary and central nervous system (9, 10, 12, 19, (37) (38) (39) (40) . With regard to the local invasiveness of CCOT, Gong et al. (7) have recently shown that MMP-9 in the stroma is associated with invasive ability. Although some reports, including our own, have described podoplanin expression in odontogenic tumors (23) (24) (25) 41) , that in CCOT has not been documented. Our present study appears to be the first to have examined podoplanin expression in CCOT. We found that expression of podoplanin was present in the dental pulp, odontoblasts and intra-dental tubules of tooth-like structures in one case of CCOT associated with odontoma. Imaizumi et al. (42) and Sawa (43) have reported strong expression of podoplanin in enamel epithelia and odontoblasts in the bell stage tooth germ of the mouse. Our research group has recently identified positivity for podoplanin in developing and mature odontoblasts, Tomes fibers, and pulp cells near podoplanin-positive odontoblasts in odontomas (25) . The expression of podoplanin in both normal developmental tooth germ and odontogenic tumors suggests a role of the protein in morphological changes and/or cell migration. Accumulation of samples for further study will be necessary.
In CP, expression of podoplanin was observed in all cases of the adamantinomatous type and squamous type. Immunoreactivity for podoplanin was observed mainly in the middle layer of the adamantinomatous type, but in the basal layer of the squamous type. There was a significant difference in the location of podoplanin expression between adamantinomatous-type and squamous-type CP. Embryologically (44), the adenohypophysis arises from the oral ectoderm (stomoderm) that later develops into the enamel organs and oral mucosa. Rathke's pouch evolves from the roof of the stomoderm, and the anterior wall of the pouch proliferates into the primordium of the adenohypophysis, and then subsequently differentiates into the secretory mass known as the anterior lobe of the pituitary gland (45) . The remaining stomoderm develops into enamel organs through the tooth buds and the oral mucosa of nonkeratinized squamous epithelium. The histogenesis of ordinary CP of the adamantinomatous type or squamous type, and Rathke's cleft cyst could also be explained as follows: The anterior wall of Rathke's pouch epithelium fails to evolve into the adenohypophysis and transforms into either enamel organs (adamantinomatous type) or oral mucosa composed of nonkeratinized squamous epithelium (squamous type) (45) . In fact, Seemayer et al. (46) have reported a case of pituitary craniopharyngioma with tooth formation. Different abnormalities in the developmental process may influence the different patterns of podoplanin expression in adamantinomatous-type or squamous-type CP. Although the normal oral squamous epithelium is immunonegative for podoplanin, previous studies have shown that lesions associated with severe inflammation (47), dysplasia (14) and carcinoma (12) have focal expression of the protein in the basal epithelial layer or at the proliferating periphery of tumor nests with no expression in the central areas. Podoplanin expression has also been detected in the basal layer of epithelial nests in squamous-type CP. Although no antibody specific for odontogenic epithelium is yet available, the distinctive distribution of podoplanin in squamous-type CP probably reflects a tumor showing unusual differentiation to oral mucosa rather than a focally invasive characteristic.
None of the PM cases examined showed immunoreactivity for podoplanin in any of the epithelial components. In normal skin, podoplanin expression is confined to the basal cell layer of the epidermis, sebaceous glands, and outer root sheath of hairs (41, 48) . Skin neoplasms, for example some adnexal tumors, squamous cell carcinomas, and basal cell carcinomas, show podoplanin expression (49) (50) (51) . No expression of podoplanin was detected in tumor nests of PM, but a positive reaction for the protein was observed in osteoblasts or osteocyte-like cells of osseous tissues in the late regressive stage of PM. It has been reported that podoplanin expression is evident in rat osteoblasts and osteocytes (15) , although the mechanism responsible for its expression is unknown. Ishige et al. (52) reported that, in PM, production of hair protein and induction of apoptosis may occur at the same time. The reason for the lack of podoplanin expression in PM may be related to apoptosis and unusual hair differentiation.
In conclusion, we have described the expression of podoplanin in three different types of tumors expressing hard α-keratin: CCOT, CP and PM. Podoplanin-positive cells were particularly evident in the peripheral layer of tumor nests of CCOT, being apparently related to the neoplastic nature of the tumor, and suggesting a role of podoplanin in local invasiveness. In addition, epithelial cells adjacent to ghost cells showed specific staining for podoplanin.
